Segmental bone defects resulting from delayed or non-union of fractures, congenital defects, or resection of bone metastases are a significant clinical concern and cost the U.S. healthcare system greater than $28 billion per year. Delivery of growth factors such as bone morphogenetic protein 2 (BMP-2) from collagen sponges is an effective clinical alternative to autografts and allografts in the treatment of bone defects and shows the economic viability of these approaches, with sales of nearly $1 billion for Medtronic's Infuse system. However, safety concerns such as ectopic bone growth due to rapid and uncontrolled release of BMP-2 limit FDA approved applications of this delivery system to lumbar spinal fusion and tibial fracture. We propose to develop a hydrogel delivery system based on a family of proteins called keratins that will serve as a matrix for infiltrating regenerative cells nd as a means to tailor BMP-2 delivery. The inherent disulfide cross-links found in keratin can be modulated by simple chemical modification, thereby controlling the rate of scaffold degradation. Because BMP-2 delivery correlates with scaffold degradation, modulation of the disulfide cross-linking provides a means to tailor the delivery of BMP-2 for safe and effective bone healing. The long-term goal of this research is to develop a biomaterial superior to existing systems by tailoring the delivery of growth factors such as BMP-2 for optimal healing response within the context of a material that can provide a physical matrix to regenerating bone cells. The specific goal of this proposal is to demonstrate the effect of modulating disulfide cross-linking in keratin hydrogels on rates of scaffold degradation, BMP-2 release, and BMP-2 bioactivity to promote bone regeneration. We will use three aims to achieve this goal:
Aim 1 : Modulate the disulfide cross-linking density inherent in keratin hydrogels to promote favorable material and biological properties.
Aim 2 : Determine release kinetics and bioactivity of BMP-2 delivered from keratin hydrogels.
Aim 3 : Assess the effect of modulating the rate of BMP-2 delivery with keratin hydrogels on bone regeneration in a critically-sized segmental rat femur defect model. The proposed experiments will specifically address the ability of keratin hydrogels to promote improved bone regeneration and safety profiles compared to existing biomaterial carriers. More generally, these studies will demonstrate the utility of keratin hydrogels as a tunable delivery platform for growth factors in restorative medicine approaches that seek to use therapeutic molecules to direct healing in states of injury or disease.
Large bone defects such as those resulting from fractures, congenital diseases, or cancer have a high rate of incomplete healing that could be improved by the safe delivery of molecules called growth factors. The goal of this proposal is to develop a system based on a material known as keratin that can safely and effectively deliver a particular growth factor known as BMP-2 that can heal bone injuries. We will assess the ability of this keratin system to promote bone regeneration in an animal model as a step towards treating large bone defects in humans.
|Ham, Trevor R; Lee, Ryan T; Han, Sangheon et al. (2016) Tunable Keratin Hydrogels for Controlled Erosion and Growth Factor Delivery. Biomacromolecules 17:225-36|
|Tomblyn, Seth; Pettit Kneller, Elizabeth L; Walker, Stephen J et al. (2016) Keratin hydrogel carrier system for simultaneous delivery of exogenous growth factors and muscle progenitor cells. J Biomed Mater Res B Appl Biomater 104:864-79|
|Kowalczewski, Christine J; Saul, Justin M (2015) Surface-mediated delivery of siRNA from fibrin hydrogels for knockdown of the BMP-2 binding antagonist noggin. Acta Biomater 25:109-20|
|Han, Sangheon; Ham, Trevor R; Haque, Salma et al. (2015) Alkylation of human hair keratin for tunable hydrogel erosion and drug delivery in tissue engineering applications. Acta Biomater 23:201-13|
|Kowalczewski, Christine J; Tombyln, Seth; Wasnick, David C et al. (2014) Reduction of ectopic bone growth in critically-sized rat mandible defects by delivery of rhBMP-2 from kerateine biomaterials. Biomaterials 35:3220-8|
|Christ, George J; Saul, Justin M; Furth, Mark E et al. (2013) The pharmacology of regenerative medicine. Pharmacol Rev 65:1091-133|